Actively Recruiting
Safety and Effectiveness of the CG-100 Intraluminal Bypass Device Compared to Protective Stoma in Rectal Cancer Surgery A Randomized Open Label Trial
Led by Colospan Ltd. · Updated on 2026-07-06
250
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and efficacy of the CG-100 intraluminal bypass device in reducing the need for protective stoma creation in patients undergoing mesorectal excision for rectal cancer. This trial compares the new device with the standard practice of creating a protective stoma during surgery to prevent complications from anastomotic leaks. The study addresses the issue that many patients receive a stoma without benefit, exposing them to potential complications unnecessarily. Participants are randomly assigned to one of two groups one receiving the CG-100 device during rectal cancer surgery, which delays stoma creation until 10 days post-surgery only if required, and the other receiving the standard protective stoma during surgery. The device is removable and temporary, designed to postpone stoma creation for patients with an anastomosis defect, allowing quicker recovery for those without defects. Surgery approaches include open, laparoscopic, or robotic mesorectal excision. During the trial, participants are monitored for stoma creation rates and complication incidence up to 39 weeks after surgery. Follow-up evaluations include assessments of safety and effectiveness, with adherence to mechanical bowel preparation and scheduled surgical procedures. The total participation duration spans from surgery through postoperative follow-up to assess clinical outcomes and device impact on recovery.
CONDITIONS
Brief Title
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Research Team
B
Boaz Assaf
S
Shelly Sharon, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here